 |
June 2011
Matt B Mahoney joins Brainwave as Director of Business Development - North American Region. Matt B. Mahoney has been working closely with Drosophila for over ten years. After studying genetics at the University of California, Berkeley, Matt joined the Alzheimer's disease team at Exelixis Inc., where he ran forward genetic screens for various clients. Subsequently, he was recruited to EnVivo Pharmaceuticals, where he helped to optimize and run their Drosophila behavioral screening platform and was integral to the identification of multiple treatment candidates for neurodegenerative diseases. This group spun off into a separate company, Vitruvean, LLC, where Matt was responsible for Drosophila-based drug screening, marketing and business development. This invaluable experience is now focused on the development of Brainwave-Discovery's business in the USA and Canada. Customers in this region should contact Matt directly on m.mahoney@brainwave-discovery.com
|